Arizona couple Michael and Julie Carroll have lost a combined 177 lbs. on a GLP-1 weight loss drug and say their lives have ...

Michael Carroll didn't go out in public and couldn't put on his own socks. Then he and wife Julie began taking a GLP-1 ...

The New Year's Day event, which killed one and injured seven, garnered reactions online ridiculing CEO Elon Musk and ...

After she hit rock bottom over Christmas, mum-of-one Verity Bambury switched up her lifestyle and started a diet which saw ...

PEOPLE are oddly divided over breakfast habits – especially when it comes to weight loss. Whether you’re a devoted breakfast ...

Bitter orange is a hybrid citrus known for its culinary and medicinal applications. Here, find out who could benefit from ...

Imagine feeling stuck—tired, weighed down, and far from the healthiest version of yourself. That’s exactly where I found myself a year ago, after a devastating car ...

As we untangle the ever-complicated web of weight loss guidance, it's essential to remember one golden rule: for weight loss, ...

Right now, Novo stock is trading at a forward price-to-earnings (P/E) multiple of 22.5 -- its lowest level in well over a year. I think now is a terrific opportunity to scoop up shares of Novo on the ...

Eli Lilly's Zepbound is challenging Wegovy in the obesity market, while U.S. health care costs are set to rise 9% in 2025, driven by specialty drugs and inflation.

Hims & Hers' robust Q3 2024 performance, driven by a 44% increase in subscribers and 77% y/y revenue growth, underscores its ...

These drugs, called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), work in several different ways to help people lose ...